| Literature DB >> 25880911 |
Linda Clare1, Sharon M Nelis2, Ian R Jones3, John V Hindle4, Jeanette M Thom5, Julie A Nixon6, Jennifer Cooney7, Carys L Jones8, Rhiannon Tudor Edwards9, Christopher J Whitaker10.
Abstract
BACKGROUND: Lifestyle factors represent prime targets for behaviour change interventions to promote healthy ageing and reduce dementia risk. We evaluated a goal-setting intervention aimed at promoting increased cognitive and physical activity and improving mental and physical fitness, diet and health.Entities:
Mesh:
Year: 2015 PMID: 25880911 PMCID: PMC4337106 DOI: 10.1186/s12888-015-0402-4
Source DB: PubMed Journal: BMC Psychiatry ISSN: 1471-244X Impact factor: 3.630
Figure 1Agewell trial consort diagram.
Sample characteristics for the whole sample and for each group, and between-group statistical comparisons
| Whole sample | Information (IC) | Goal-setting (GS) | Goal-setting with mentoring (GM) | B | ||
|---|---|---|---|---|---|---|
| N = 75 | N = 27 | N = 24 | N = 24 | |||
|
|
|
|
|
|
| |
| Years of education | 13.33 (2.93; 9–20) | 12.70 (2.91; 9–19) | 13.79 (3.18; 9–20) | 13.58 (2.68; 10–18) | . | |
| Perceived social status (on 10 rung ladder) | 6.53 (1.84; 1–10) | 6.51 (1.71; 1–10) | 6.54 (1.95; 2–10) | 6.54 (1.95; 2–9) | . | |
|
|
|
|
| |||
| Age | 68.21 (7.92; 51–84) | 70.22 (7.77; 52–84) | 67.50 (7.66; 52–78) | 68.21 (7.92; 51–84) | ||
| LEQ | ||||||
| Early life | 25.08 (6.08; 13–39.8) | 23.74 (5.07; 13–31.80) | 26.53 (6.63; 15–38) | 25.21 (6.08; 13–39.8) | .07 | .99 |
| Mid life | 28.66 (6.73; 12.5-41.5) | 28.49 (6.26; 17.0-39.0) | 29.13 (7.23; 16–41.5) | 28.40 (6.98; 12.5-27.5) | ||
| Later life | 28.11 (4.75; 16.20-28.4) | 29.11 (4.23; 21–37.2) | 26.97 (4.82; 16.2-33.8) | 28.00 (5.20; 18.4-38.4) | ||
| Total | 82.08 (14.59; 47.2-108.8)# | 81.23 (12.94; 51–99.8) | 82.77 (16.65; 47.2-108.8) | 82.43 (15.04; 60.1-108.8) | ||
|
|
|
|
|
|
| |
| Gender | ||||||
| Male | 10 (13.3) | 4 (14.8) | 1 (4.2) | 5 (20.8) | ||
| Female | 65 (86.7) | 23 (85.2) | 23 (95.8) | 19 (79.2) | ||
| Marital status | ||||||
| Single | 6 (8.0) | 0 | 2 (12.5) | 3 (12.5) | ||
| Married* | 39 (52.0) | 14 (51.9) | 11 (45.8) | 14 (58.3) | ||
| Divorced | 6 (8.0) | 2 (7.4) | 3 (12.5) | 1 (4.2) | ||
| Widowed | 20 (26.7) | 10 (37.0) | 6 (25.0) | 4 (16.7) | ||
| Cohabiting | 4 (5.3) | 1 (3.7) | 1 (4.2) | 2 (8.3) | ||
| Living situation | ||||||
| Living alone | 26 (34.7) | 12 (44.4) | 8 (33.3) | 6 (25.0) | 2 | |
| Living with others | 49 (65.3) | 15 (55.6) | 16 (66.7) | 18 (75.0) | ||
| Socio-economic status | ||||||
| Unskilled | 7 (9.3) | 2 (7.4) | 4 (16.7) | 1 (4.2) | 1 | |
| Partly skilled | 10 (13.3) | 3 (11.1) | 4 (16.7) | 3 (12.5) | ||
| Skilled manual | 7 (9.3) | 2 (7.4) | 0 | 5 (20.8) | ||
| Skilled non-manual | 21 (28.0) | 10 (37.0) | 4 (16.7) | 7 (29.2) | ||
| Managerial and technical | 26 (34.7) | 10 (37.0) | 10 (41.7) | 6 (25.0) | ||
| Professional | 4 (5.3) | 0 | 2 (8.3) | 2 (8.3) | ||
| Level of Education | ||||||
| No formal qualifications | 23 (30.7) | 12 (44.4) | 4 (16.7) | 7 (29.2) | 6 | |
| Secondary school | 21 (28.0) | 6 (22.2) | 7 (29.2) | 8 (33.3) | ||
| Vocational training | 7 (9.3) | 2 (7.4) | 3 (12.5) | 2 (8.3) | ||
| University degree | 15 (20.0) | 5 (18.5) | 5 (20.8) | 5 (20.8) | ||
| Higher degree | 9 (12.0) | 2 (7.4) | 5 (20.8) | 2 (8.3) | ||
| Employment | ||||||
| Retired or unemployed | 59 (78.6) | 24 (89.9) | 19 (79.2) | 16 (66.7) | ||
| Employed | 16 (21.3) | 3 (11.1) | 5 (20.8) | 8 (33.3) | ||
| Social capital | ||||||
| Poor | 50 (66.7) | 19 (70.4) | 15 (62.5) | 16 (66.7) | ||
| Good | 25 (33.3) | 8 (29.6) | 9 (37.5) | 8 (33.3) | ||
| Material deprivation | ||||||
| None | 19 (25.3) | 10 (37.0) | 7 (29.2) | 2 (8.3) | 6 | |
| Moderate | 40 (53.3) | 12 (44.4) | 13 (54.2) | 15 (62.5) | ||
| High | 16 (21.3) | 5 (18.5) | 4 (16.7) | 7 (29.2) | ||
| Disadvantaged | ||||||
| Civic participation | 4 (5.3) | 1 | 2 | 1 | 1 | .59 |
| Social participation | 0 | 0 | 0 | 0 | ||
| Leisure participation | 6 (8.0) | 1 | 3 | 2 | ||
| Cultural participation | 0 | 0 | 0 | 0 | ||
| Social support | 1 (1.3) | 0 | 1 | 0 | ||
| Contact with others | 32 (42.7) | 13 (48.1) | 11 (45.8) | 8 (33.3) | ||
| Subjective health | ||||||
| Poor/very poor | 2 (2.8) | 0 | 0 | 2 (8.3) | 1 | |
| Not too good | 4 (5.3) | 4 (14.8) | 3 (12.5) | 0 | ||
| Good/very good | 64 (85.3) | 23 (85.2) | 21 (87.5) | 22 (91.7) | ||
*6 married couples participated in the study.
#Based on N = 66 (IC – 25; GS – 20; GM – 21) – not all participants were retired at the time of completing the LEQ and hence the post-retirement section could not be completed by these participants.
Examples of participants’ goals
| Domain | Goal |
|---|---|
| Physical activity | I will attend at least a one hour exercise class per week. |
| I will be able to run to the end of Nefyn beach. | |
| I will start swimming and go once a week. | |
| I will cycle for half an hour each week. | |
| I will walk one mile on four days a week. | |
| Cognitive activity | I will attend computer classes and learn to email and send attachments. |
| In 12 months’ time I will be able to do a moderate Sudoku. | |
| In 12 months’ time I will be able to save a document on the computer and move it to another file. | |
| I will do a crossword 3-4 times a week. | |
| In 12 months’ time I will have completed a 60 credit course. | |
| Diet and health | I will increase my fish intake from once to twice a week. |
| I will attend cooking classes at the Centre. | |
| I will cook my own meals three times a week. | |
| In 12 months’ time I will have lowered my cholesterol level by 2 points. | |
| In 12 months’ time I will be a non-smoker. |
Figure 2Ratings (on a 0 – 10 scale) of goal performance, and satisfaction with performance, in the goal-setting and goal-setting with mentoring groups at initial and follow-up assessments.
Participation in centre activities and extent of goal attainment
| Whole sample | Information (IC) | Goal-setting (GS) | Goal-setting with mentoring (GM) | Between-group statistical comparison (Kruskal-Wallis ~ or Fisher’s Exact Test) | ||
|---|---|---|---|---|---|---|
| N = 75 | N = 27 | N = 24 | N = 24 | |||
|
|
|
|
|
|
| |
| Centre activities undertaken | 2.70 (2.50; 0–13) | 2.78 (2.26; 0–10) | 2.38 (2.16; 0–8) | 2.91 (3.01; 0–13) | .66 | |
| Sessions attended | 34.00 (35.62; 0–131) | 29.07 (35.04; 0–126) | 36.34 (38.84; 0–131) | 37.50 (37.10; 0–117) | .61 | |
| Sessions by type | ||||||
| Cognitive | 11.54 (11.03; 1–43) | 6.33 (7.66; 1–30) | 14.00 (13.03; 1–43) | 14.93 (11.02; 1–35) | .07 | |
| Physical | 29.60 (26.97; 1–109) | 22.00 (20.85; 1–78) | 34.85 (29.98; 2–109) | 36.72 (31.55; 1–84) | .27 | |
| Art and Craft | 20.55 (22.32; 1–76) | 22.00 (26.61; 1–76) | 20.00 (23.35; 3–66) | 19.30 (20.08; 1–60) | .92 | |
| Number of goals set | 2.85 (1.2; 1–5, n = 48) | - | 2.83 (1.09; 1–5) | 2.88 (1.33; 1–5) | .99 | |
|
|
|
|
|
|
| |
| Goal attainment1 | ||||||
| <25% | 31 (22.6) | - | 15 (21.7) | 16 (23.5) | 5.29 | .26 |
| 25% | 9 (6.6) | 7 (10.1) | 2 (2.9) | |||
| 50% | 19 (13.9) | 6 (8.7) | 13 (19.1) | |||
| 75% | 22 (16.1) | 11 (15.9) | 11 (16.2) | |||
| 100% | 39 (28.5) | 20 (29.0) | 19 (27.9) | |||
1. The process of goal-setting included specification of what level of behavioural change would constitute 25%, 50%, 75% and 100% goal attainment. At follow-up, alongside participants’ ratings of performance and satisfaction, the extent of goal attainment was rated for each goal.
2. ~ SPSS v. 20 does not provide values for H but simply reports on whether or not the null hypothesis should be retained, with p values.
Figure 3Goal attainment (%) in the goal-setting and goal-setting with mentoring groups: number of goals meeting each attainment level.
Mean scores on primary and secondary outcome measures at baseline and follow-up in each condition, with effect sizes for benefits at follow-up
| IC | N = 27 | GS | N = 24 | GM | N = 24 | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Variable | Mean (SD) Range n baseline | Mean (SD) range n follow-up | t | df | p | ES | Mean (SD) range n baseline | Mean (SD) range n follow-up | t | df | p | ES | Mean (SD) range n baseline | Mean (SD) range n follow-up | t | df | p | ES |
| (max possible score) | ||||||||||||||||||
|
| ||||||||||||||||||
| FCAS (100) | 48.25 (8.91) | 47.66 (7.95) | .49 | 26 | .62 | -.09 | 45.90 (6.72) | 47.14 (8.86) | -.89 | 20 | .38 | .19 | 44.00 (9.22) | 45.05 (9.36) | -.76 | 21 | .46 | .16 |
| 28.0-60.0, 27 | 31.0-62.0, 27 | 24.0-59.0, 24 | 22.0-63.0, 21 | 19.0-64.0,24 | 26.0-61.0, 22 | |||||||||||||
| PASE (361) | 117.62 (33.44) | 112.96 (46.91) | .48 | 26 | .63 | -.09 | 121.00 (41.85) | 124.86 (47.63) | -.43 | 20 | .67 | .09 | 119.17 (50.33) | 136.16 (53.47) | −1.57 | 21 | .13 | .33 |
| 60.8-214.4, 27 | 27.1-222.7, 27 | 38.8-215.0, 24 | 62.4-226.1, 21 | 25.0-247.2, 24 | 69.4-297.2, 22 | |||||||||||||
|
| ||||||||||||||||||
| GSES (40) | 31.11 (5.45) | 30.96 (6.99) | .14 | 26 | .89 | -.02 | 31.57 (4.96) | 31.76 (4.06) | -.17 | 20 | .86 | .03 | 31.45 (3.84) | 31.36 (4.38) | .14 | 21 | .89 | -.03 |
| 18.0-38.0, 27 | 16.0-39.0, 27 | 16.0-38.0, 24 | 27.0-40.0, 21 | 22.0-39.0,24 | 21.0-38.0, 22 | |||||||||||||
| CES-D (60)* | 10.62 (7.91) | 9.85 (9.43) | .44 | 26 | .66 | .08 | 11.85 (10.45) | 10.38 (6.49) | .86 | 20 | .39 | .19 | 7.36 (5.46) | 9.73 (6.41) | −1.95 | 21 | .07 | -.41 |
| 1.0-34.0, 27 | 1.0-40.0, 27 | 0.0-41.0, 24 | 0.0-23.0, 21 | 0.0-25.0, 24 | 0.0-24.0, 22 | |||||||||||||
| CASP-19 (57) | 45.51 (6.95) | 45.59 (8.27) | -.09 | 26 | .93 | .02 | 42.00 (10.17) | 43.90 (9.15) | -.15 | 20 | .16 | .32 | 45.59 (6.61) | 45.18 (5.51) | .46 | 21 | .62 | .02 |
| 26.0-55.0, 27 | 22.0-56.0, 27 | 10.0-57.0, 24 | 24.0-57.0, 21 | 26.0-55.0, 24 | 32.0-54.0, 22 | |||||||||||||
|
| ||||||||||||||||||
| MOCA (30) | 25.88 (2.85) | 26.37 (2.85) | −1.16 | 26 | .26 | .22 | 25.80 (3.61) | 26.23 (3.14) | -.78 | 20 | .44 | .17 | 26.32 (2.64) | 27.23 (2.05) | −2.27 | 21 | .03 | .48 |
| 20.0-30.0, 27 | 19.0-30.0, 27 | 15.0-30.0, 24 | 16.0-29.0, 21 | 19.0-30.0, 24 | 24.0-30.0, 22 | |||||||||||||
| CVLT-II Immediate recall (80) | 42.91 (9.17) | 43.20 (11.72) | -.17 | 26 | .87 | .03 | 46.10 (9.35) | 47.47 (11.08) | -.79 | 18 | .43 | .18 | 48.94 (10.27) | 52.35 (11.31) | −1.45 | 16 | .17 | .35 |
| 27.0-57.0, 26 | 22.0-67.0, 24 | 15.0-64.0, 23 | 32.0-67.0, 19 | 27.0-63.0, 24 | 34.0-72.0, 17 | |||||||||||||
| CVLT-II Delay recall (16) | 9.33 (3.21) | 10.90 (2.73) | −2.55 | 20 | .02 | .56 | 9.31 (2.23) | 10.10 (2.96) | −1.66 | 18 | .11 | .38 | 10.41 (3.00) | 11.35 (3.48) | −1.93 | 16 | .07 | .47 |
| 1.0-15.0, 25 | 7.0-16.0, 21 | 0.0-14.0, 23 | 6.0-16.0, 19 | 4.0-15.0, 24 | 4.0-16.0, 17 | |||||||||||||
| TMT T4-T2 (no max) | 69.81 (38.86) | 76.44 (42.81) | -.94 | 26 | .35 | -.18 | 69.04 (36.21) | 65.47 (31.98) | .49 | 20 | .63 | .11 | 59.18 (30.20) | 62.14 (31.32) | -.38 | 21 | .71 | -.08 |
| 27.0-57.0, 25 | 16.0-169.0, 27 | 19.0-180.0, 24 | 12.0-129.0, 21 | 18.0-137.0, 24 | 20.0-121.0, 22 | |||||||||||||
| VF (no max) | 38.59 (10.87) | 41.74 (10.74) | −2.05 | 26 | .05 | .39 | 36.96 (14.58) | 43.47 (15.24) | −4.15 | 20 | <.001 | .90 | 36.64 (13.92) | 39.41 (13.74) | −1.80 | 21 | .09 | .38 |
| 15.0-60.0, 27 | 16.0-61.0, 27 | 8.0-56.0, 24 | 10.0-68.0, 21 | 7.0-60.0, 24 | 10.0-63.0, 22 | |||||||||||||
|
| ||||||||||||||||||
| Body fat percentage* | 38.57 (9.43) | 36.94 (7.53) | 1.65 | 21 | .11 | .35 | 38.43 (7.26) | 37.08 (6.71) | 1.49 | 18 | .15 | .34 | 39.29 (9.94) | 37.32 (7.28) | 1.44 | 15 | .17 | .36 |
| 23.2-69.0, 26 | 23.0-50.6, 23 | 22.0-53.0, 23 | 23.3-47.1, 19 | 16.0-61.0, 21 | 23.6-48.4, 17 | |||||||||||||
| BMI* | 29.22 (5.49) | 28.75 (5.23) | 2.17 | 22 | .04 | .80 | 27.92 (4.26) | 27.96 (4.41) | -.20 | 19 | .84 | .04 | 29.74 (4.49) | 29.00 (4.37) | 1.73 | 18 | .10 | .40 |
| 21.2-41.8, 27 | 20.3-40.0, 23 | 17.7-35.0, 24 | 18.0-35.8, 20 | 21.7-39.5, 24 | 21.2-37.5, 19 | |||||||||||||
| MEDAS (14) | 6.51 (2.42) | 7.22 (2.13) | −1.96 | 26 | .06 | .39 | 6.33 (2.26) | 6.52 (2.46) | -.61 | 20 | .55 | .13 | 6.55 (2.18) | 7.18 (1.71) | −1.33 | 21 | .20 | .28 |
| 1.0-10.0, 27 | 1.0-11.0, 27 | 1.0-10.0, 24 | 2.0-11.0, 21 | 1.0-10.0, 24 | 5.0-11.0, 22 | |||||||||||||
| Total cholesterol* | 5.76 (1.20) | 5.65 (1.07) | .93 | 18 | .36 | .20 | 6.00 (1.07) | 5.57 (1.03) | 1.71 | 16 | .10 | .42 | 5.59 (1.07) | 5.31 (1.24) | .83 | 13 | .42 | .22 |
| 3.4-8.0, 22 | 3.5-7.7, 22 | 4.8-8.6, 21 | 3.8-7.3, 18 | 3.6-7.8, 20 | 2.7-6.6, 15 | |||||||||||||
| QRISK* | 21.51 (10.33) | 20.20 (9.50) | 3.39 | 25 | .002 | .66 | 18.02 (10.13) | 16.88 (9.92) | 2.76 | 20 | .01 | .57 | 17.86 (8.29) | 16.46 (8.70) | 2.73 | 20 | .01 | .60 |
| 4.9-42.5, 27 | 4.2-36.4, 26 | 3.3-45.3, 24 | 5.9-42.3, 21 | 4.6-34.1, 24 | 3.6-31.5, 21 | |||||||||||||
|
| ||||||||||||||||||
| Predicted aerobic capacity | 18.51 (3.23) | 20.09 (4.83) | −1.87 | 9 | .09 | .59 | 18.29 (4.00) | 18.29 (3.94) | .001 | 10 | .99 | 0 | 17.99 (3.43) | 19.55 (5.40) | −2.30 | 10 | .05 | .69 |
| 10.6-23.0, 16 | 14.7-29.2, 10 | 12.7-18.0, 17 | 13.6-25.2, 11 | 12.5-19.1, 13 | 12.9-30.3,12 | |||||||||||||
| Up and go* | 5.38 (.80) | 6.67 (3.74) | −1.72 | 21 | .09 | -.37 | 5.03 (.67) | 5.05 (1.16) | -.14 | 18 | .89 | -.02 | 5.62 (1.81) | 5.37 (1.18) | 1.04 | 17 | .31 | .25 |
| 3.8-9.1, 26 | 4.1-18.6, 23 | 3.8-6.8, 23 | 3.8-9.2, 19 | 3.8-12.1, 24 | 3.94-8.78, 18 | |||||||||||||
| Sit to stand | 14.42 (2.39) | 14.00 (3.47) | .86 | 21 | .39 | -.18 | 14.89 (2.80) | 15.57 (3.62) | −1.34 | 18 | .19 | .31 | 13.94 (2.14) | 14.94 (2.43) | −2.66 | 15 | .02 | .66 |
| 8.0-19.0, 26 | 7.0-21.0, 21 | 10.0-21.0, 23 | 11.0-25.0, 19 | 6.0-17.0, 23 | 10.21.0, 17 | |||||||||||||
*Lower scores better.
Results of ANCOVA and effect sizes for planned contrasts
| Measure | Group | n | Estimated marginal means at follow-up (and standard errors) | Covariate | Significance | Effect size | |||
|---|---|---|---|---|---|---|---|---|---|
| (maximum possible score) | F | P | F | p | Contrast 1# | Contrast 2+ | |||
| GS + GM vs. IC | GM vs. GS | ||||||||
|
| |||||||||
| Florida cognitive activities scale (100) | IC | 27 | 46.13 (1.17) | 75.75 | <.001 | .25 | .78 | .15 | -.11 |
| GS | 21 | 47.38 (1.31) | |||||||
| GM | 22 | 46.71 (1.30) | |||||||
| Physical activity scale elderly (361) | IC | 27 | 113.78 (8.50) | 17.78 | <.001 | 1.55 | .22 | .37 | .28 |
| GS | 21 | 123.85 (9.63) | |||||||
| GM | 22 | 136.14 (9.41) | |||||||
|
| |||||||||
| General self-efficacy scale (40) | IC | 27 | 31.12 (.87) | 33.58 | <.001 | .07 | .93 | .07 | -.07 |
| GS | 21 | 31.62 (.98) | |||||||
| GM | 22 | 31.3 (.96) | |||||||
| CES-Depression Score (60)* | IC | 27 | 9.53 (1.29) | 23.82 | <.001 | .37 | .68 | -.11 | -.24 |
| GS | 21 | 9.45 (1.47) | |||||||
| GM | 22 | 11.02 (1.45) | |||||||
| CASP-19 (57) | IC | 27 | 44.77 (.90) | 125.08 | <.001 | .63 | .54 | .07 | -.34 |
| GS | 21 | 45.88 (1.03) | |||||||
| GM | 22 | 44.30 (.99) | |||||||
|
| |||||||||
| MOCA (30) | IC | 27 | 26.44 (.37) | 72.38 | <.001 | .79 | .46 | .13 | .35 |
| GS | 21 | 26.36 (.42) | |||||||
| GM | 22 | 27.02 (.41) | |||||||
| CVLT-II Immediate recall total (80) | IC | 24 | 45.41 (1.76) | 57.02 | <.001 | 1.18 | .31 | .35 | .30 |
| GS | 19 | 47.09 (1.94) | |||||||
| GM | 17 | 49.67 (2.09) | |||||||
| CVLT-II Delayed recall total (16) | IC | 21 | 11.13 (.49) | 47.68 | <.001 | .61 | 55 | -.25 | .20 |
| GS | 19 | 10.35 (.52) | |||||||
| GM | 17 | 10.80 (.55) | |||||||
| Trail making test T4-T2 (no max.)* | IC | 27 | 74.57 (6.08) | 24.63 | <.001 | .79 | .46 | .31 | .18 |
| GS | 21 | 64.01 (6.89) | |||||||
| GM | 22 | 65.84 (6.76) | |||||||
| Verbal fluency (no max.) | IC | 27 | 40.81 (1.41) | 149.83 | <.001 | 1.65 | .19 | .17 | -.52 |
| GS | 21 | 43.93 (1.60) | |||||||
| GM | 22 | 40.12 (1.57) | |||||||
|
| |||||||||
| Body fat percentage* | IC | 22 | 37.05 (.81) | 142.78 | <.001 | .04 | .96 | -.01 | .09 |
| GS | 19 | 37.29 (.87) | |||||||
| GM | 17 | 36.93 (.95) | |||||||
| BMI* | IC | 23 | 28.51 (.27) | 718.12 | <.001 | 1.31 | .27 | -.08 | .52 |
| GS | 20 | 28.98 (.29) | |||||||
| GM | 19 | 28.75 (.30) | |||||||
| MEDAS | IC | 27 | 7.19 (.32) | 47.19 | <.001 | .87 | .42 | -.20 | -.32 |
| GS | 21 | 6.61 (.36) | |||||||
| GM | 22 | 7.14 (.35) | |||||||
| Cholesterol* | IC | 19 | 5.68 (.20) | 34.32 | <.001 | .44 | .64 | .27 | .00 |
| GS | 18 | 5.44 (.21) | |||||||
| GM | 15 | 5.45 (.23) | |||||||
| QRISK* | IC | 26 | 18.12 (.40) | 1388.21 | <.001 | .13 | .88 | .07 | .13 |
| GS | 21 | 18.10 (.44) | |||||||
| GM | 21 | 17.84 (.44) | |||||||
|
| |||||||||
| Predicted aerobic capacity | IC | 10 | 19.79 (.74) | 93.31 | <.001 | 1.66 | .21 | -.31 | -.69 |
| GS | 11 | 18.25 (.70) | |||||||
| GM | 12 | 19.87 (.70) | |||||||
| Up and go* | IC | 22 | 6.64 (.49) | 11.93 | .001 | 2.67 | .08 | .62 | .09 |
| GS | 19 | 5.33 (.53) | |||||||
| GM | 18 | 5.13 (.54) | |||||||
| Sit to stand | IC | 21 | 14.02 (.45) | 79.97 | <.001 | 2.50 | .09 | .61 | .16 |
| GS | 19 | 15.12 (.48) | |||||||
| GM | 17 | 15.46 (.52) | |||||||
*Lower scores better.
#Contrast 1 examines whether goal-setting (either alone or with added mentoring) produced greater benefits than control; a positive effect size favours goal-setting and a negative effect size favours control.
+Contrast 2 examines whether adding mentoring to goal-setting produced greater benefits than goal-setting alone; a positive effect size favours goal-setting with mentoring and a negative effect size favours goal-setting alone.
Costs of setting up and running the centre, and of developing and delivering the intervention
| Cost of setting up the centre (annuitized over 3 years) | |||
|---|---|---|---|
| Task | Cost | ||
| ACGM development officer, 50% FTE | £5,377.57 | ||
| Volunteer training | £356.93 | ||
| Administration costs | £356.93 | ||
| Promoting the centre | £356.93 | ||
| Equipping the centre | £3,390.87 | ||
| Recruiting centre staff/facilitators | £1,225.50 | ||
|
|
| ||
|
|
| ||
|
| |||
| Task | Cost | ||
| ACGM centre co-ordinator’s salary | £9,000.00 | ||
| Rent of an office for the co-ordinator | £5,000.00 | ||
| Management of centre staff | £14,040.94 | ||
| Rent of the centre | £4,382.50 | ||
| Administration costs including utility bills and travel reimbursement | £5,699.00 | ||
|
|
| ||
|
|
| ||
|
| |||
| Intervention development time | £590.90 | ||
| Training staff to deliver the interviews and mentoring | £144.80 | ||
| Supervision of staff delivering the interviews and mentoring | £126.92 | ||
|
|
| ||
|
|
| ||
|
| |||
| IC | GS | GM | |
| Initial interview cost per person | £20.32 | £30.48 | £30.48 |
| On-going telephone mentoring cost per person | N/A | N/A | £16.93 |
|
|
|
|
|
|
| |||
| IC | GS | GSM | |
| £241.77 | £251.93 | £268.86 | |
Note: IC = control, GS: goal-setting, GM: goal-setting with mentoring.
*For future studies the cost of intervention development time would not apply and hence the cost per person would reflect only the cost of staff training and supervision; this is calculated as £3.63 per participant.
Mean costs, mean QALYs accrued and mean ICECAP-O change at 12 months
| IC (n = 27) | GS (n = 21) | GM (n = 22) | |
|---|---|---|---|
| Mean cost (s.d.) | £1,482.00 (£3,495.88) | £1,510.59 (£3,825.71) | £1,432.75 (£2,312.49) |
| Mean QALYs (s.d.) | 0.85 (0.18) | 0.87 (0.17) | 0.83 (0.24) |
| Mean ICECAP-O change (s.d.) | −0.01 (0.13) | 0.03 (0.07) | 0.00 (0.10) |
Note: IC = control, GS: goal-setting, GM: goal-setting with mentoring.